Moderna Short Sellers Hit With $4.8 Billion Loss as Stock Soars 
REPAY Stock Rises After Visa Platform Connect Collaboration 
Samsung Eyes $72 Billion Shareholder Return Plan as AI Chip Boom Fuels Profits 
Alphabet Eyes First Australian Dollar Bond as AI Spending Drives Funding Push 
Google to Buy Spirit Airlines Business Data for $10 Million to Train AI 
Anthropic Eyes $10B-Plus Credit Line Ahead of Potential IPO 
CK Hutchison Seeks $1.5 Billion From Panama Over Canal Ports 
OpenAI Revenue Rises 18% in Q2 as Losses Widen and Anthropic Surges Ahead 
Hermès Stock Downgraded by RBC as Luxury Growth Premium Narrows 
Unitree Robotics Shares Soar Over 600% in Shanghai Market Debut 
Nordson Stock Rises as Q3 Earnings Beat Estimates, Outlook Raised 
Coty Revenue Beats Estimates as Beauty Demand Holds Firm 
Sun Pharma Wins U.S. Appeal in Pfizer Lipitor Antitrust Case 
Toyota, Honda Shares Rise on Possible U.S.-Canada Auto Tariff Cut 
Standard Chartered Expands Hedge Fund Access for Wealth Clients 
SEC Sues Former Tricolor Executives Over $1.9 Billion Investor Fraud Scheme 
Add as a preferred source on Google
Canada blocked bulk exports of prescription drugs to the US as it would cause or worsen a drug shortage at home.
The said importation from Canada is President Donald Trump's strategy of lowering some drug prices in the US, which he touted in his debate with President-elect Joe Biden.
Many Canadian drug suppliers opposed Trump's plan as it could lead to shortages,
The “Importation Prescription Drugs” rule in the US would allow licensed US pharmacists or wholesalers to import in bulk certain prescription drugs intended for the Canadian market.
According to Canada's Health Minister Patty Hajdu, companies will be required to provide information to assess existing or potential shortages, which could be as quick as within 24 hours if there is a serious or imminent health risk.
Hajdu emphasized the need for vigilance in maintaining the national drug supply noting that Canada is a small market, representing 2 percent of global drug sales, that sources 68 percent of its drugs internationally.
Canadian Prime Minister Justin Trudeau said in September that his priority was protecting the needs of Canadians in terms of pharmaceutical supplies.
